Trials and PIs

 
 

Trials and PIs

  • Dalcetrapib in patients with recent ACS with Dr Gregory Schwartz   Dr Gregory Schwartz (University of Colorado, Denver) talks to Dr Michael Blaha (Johns Hopkins, Baltimore, MD) about the effects of the cholesteryl ester transfer protein inhibitor dalcetrapib in patients with recent ACS.
  • GAUSS with Dr Evan Stein   Dr Evan Stein (Metabolic and Atherosclerosis Research Center, Cincinnati, OH) reviews goal achievement after utilizing an anti-PCSK9 antibody in statin-intolerant subjects with Dr Michael Blaha (Johns Hopkins, Baltimore, MD).
  • The NHLBI and CCTRN TIME Trial with Dr Jay Traverse   Dr Jay Traverse (Minneapolis Heart Institute, MN) talks about the effect of timing of stem-cell delivery following acute MI
  • TRILOGY ACS Platelet-Function Substudy with Dr Paul Gurbel   Dr Paul Gurbel (Sinai Hospital Center for Thrombosis Research, Baltimore, MD) discusses the first large-scale platelet-function evaluation in an ACS trial with Dr Michael Blaha (Johns Hopkins, Baltimore, MD).
  • Economic study of FREEDOM with Dr Elizabeth Magnuson   Dr Elizabeth Magnuson (Saint Luke's Mid America Heart Institute, Kansas City, MO) discusses cost-effectiveness of PCI with DES vs bypass surgery for patients with diabetes and multivessel CAD with Dr Michael Blaha (Johns Hopkins, Baltimore, MD)
  • ASPIRE with Drs Timothy Brighton and John Simes   Drs Timothy Brighton (South Eastern Area Lab Services, Prince of Wales Hospital, Sydney, Australia) and John Simes (Sydney Medical School, Australia) talk with Dr Michael Blaha (Johns Hopkins, Baltimore, MD) about aspirin for the prevention of recurrent V
  • FORWARD with Dr Alejandro Macchia   Dr Alejandro Macchia (Consorzio Mario Negri Sud, Santa Maria Imbaro, Italy) discusses omega-3 fatty acids for the prevention of recurrent symptomatic AF with Dr Michael Blaha (Johns Hopkins, Baltimore, MD).
  • OPERA with Drs Roberto Marchioli   Drs Roberto Marchioli (Consorzio Mario Negri Sud, Santa Maria Imbaro, Italy) dicusses fish oil for the prevention of postoperative AF with Dr Michael Blaha (Johns Hopkins, Baltimore, MD).
  • CARRESS-HF with Dr Bradley Bart   Dr Bradley Bart (Hennepin County Medical Center, Minneapolis, MN) talks to Dr Michael Blaha (Johns Hopkins, Baltimore, MD) about the cardiorenal rescue study in acute decompensated heart failure.
  • Cell-based therapies for myocardial regeneration with Dr Stefanie Dimmeler   Dr Stefanie Dimmeler (Frankfurt, Germany) discusses the cell-based therapies for myocardial regeneration with Dr Michael Blaha (Johns Hopkins, Baltimore, MD).
  • Swiss AMI with Dr Daniel Sürder   Dr Daniel Sürder (Fondazione Cardiocentro Ticino, Lugano, Switzerland) shares results of the Swiss multicenter intracoronary stem-cells study in acute myocardial infarction trial with Dr Michael Blaha (Johns Hopkins, Baltimore, MD).
  • BLOCK HF Study with Dr Anne Curtis   Dr Anne Curtis (University at Buffalo, NY) discussesbiventricular vs RV pacing in patients with LV dysfunction and atrioventricular block with Dr Michael Blaha (Johns Hopkins, Baltimore, MD).
  • RUTHERFORD with Dr Frederick Raal   Dr Frederick Raal (University of Witwatersrand, Johannesburg, South Africa) discusses his trial on the reduction of LDL-C with PCSK9 inhibition in heterozygous familial hypercholesterolemia disorder (RUTHERFORD) with Dr Michael Blaha (Johns Hopkins, Bal
  • The Physicians' Health Study II with Dr Howard Sesso   Dr Howard D Sesso (Brigham and Women's Hospital, Boston, MA) joins Dr Michael Blaha (Johns Hopkins, Baltimore, MD) to review multivitamins in the prevention of cardiovascular disease in men.
  • TRILOGY-ACS with Dr Matthew Roe   In this brief interview, Dr Matthew Roe (Duke University, Durham, NC) talks about prasugrel vs clopidogrel for patients with unstable angina/NSTEMI who are medically managed without revascularization, with Dr Anthony Gershlick (University Hospital Leicest
  • FAME II with Dr De Bruyne   Dr Bernard De Bruyne (OLV Clinic, Aalst, Belgium) discusses fractional flow reserve-guided PCI plus OMT vs OMT alone in patients with stable coronary artery disease.
  • GARY with Dr Christian Hamm   Dr Christian Hamm (Kerckhoff Heart and Thorax Center, Bad Nauheim, Germany) discusses the German Aortic Valve Registry (in-hospital outcomes) with Dr Anthony Gershlick (University Hospital Leicester, UK).
  • PARAMOUNT with Dr Scott Solomon   Dr Anthony Gershlick (University Hospital Leicester, UK) asks Dr Scott Solomon (Brigham and Women's Hospital, Boston, MA) about the efficacy and safety of LCZ696, a first-in-class angiotensin receptor neprilysin inhibitor, in patients with heart failure a
  • GRACE with Dr Eva Lonn   Dr Eva Lonn (McMaster University, Hamilton, ON) talks to Dr Anthony Gershlick (University Hospital Leicester, UK) about the effects of insulin glargine and of polyunsaturated fatty acids on carotid intima media thickness in high-risk diabetes.
  • AFib Ablation Pilot: ESC-EURObservational Research Program with Dr Elena Arbelo   Dr Elena Arbelo (University of Barcelona, Spain) talks to Dr Anthony Gershlick (University Hospital Leicester, UK) about the one-year follow-up of the atrial-fibrillation ablation conducted by the European Heart Rhythm Association.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.